ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation
- 31 March 2002
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 1 (2) , 145-155
- https://doi.org/10.1016/s1535-6108(02)00035-1
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Id-1, ITF-2, and Id-2 Comprise a Network of Helix-Loop-Helix Proteins That Regulate Mammary Epithelial Cell Proliferation, Differentiation, and ApoptosisJournal of Biological Chemistry, 2001
- Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signallingNature Genetics, 2000
- Gastrin is a target of the β-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposisJournal of Clinical Investigation, 2000
- Analysis of the Inhibition of MyoD Activity by ITF-2B and Full-length E12/E47Published by Elsevier ,2000
- Expression of the Dominant-Negative Regulator Id4 Is Induced during Adipocyte DifferentiationBiochemical and Biophysical Research Communications, 1999
- The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cellPublished by Elsevier ,1999
- The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitroGenes & Development, 1999
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997
- Cancer Cell CyclesScience, 1996
- Functional interaction of β-catenin with the transcription factor LEF-1Nature, 1996